An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples

Free Radical Research

Volumn 44, Issue 10, 2010, Pages 1203-1215

  Breusing, Nicolle ^a   Grune, Tilman ^a   Andrisic, Luka ^b   Atalay, Mustafa ^c   Bartosz, Grzegorz ^d   Biasi, Fiorella ^e   Borovic, Suzana ^b   Bravo, Laura ^f   Casals, Isidre ^g   Casillas, Rosario ^g   Dinischiotu, Anca ^h   Drzewinska, Joanna ^d   Faber, Heidemarie ⁱ   Fauzi, Norsyahida Mohd ^j   Gajewska, Agnieszka ^d   Gambini, Juan ^k   Gradinaru, Daniela ^l   Kokkola, Tarja ^c   Lojek, Antonin ^m   Łuczaj, Wojciech ⁿ   Margina, Denisa ^l   Mascia, Cinzia ^e   Mateos, Raquel ^f   Meinitzer, Andreas ^o   Mitjavila, Mara Teresa ^g   Mrakovcic, Lidija ^b   Munteanu, Maria Cristina ^h   Podborska, Martina ^m   Poli, Giuseppe ^e   Sicinska, Paulina ^d   Skrzydlewska, Elzbieta ⁿ   Vina, Jose ^k   Wiswedel, Ingrid ⁱ   Zarkovic, Neven ^b   Zelzer, Sieglinde ^o   Spickett, Corinne M ^j   more..

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF LODZ   (Poland)

^e UNIVERSITY OF TURIN   (Italy)

^f INSTITUTO DEL FRÍO CSIC   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY OF BUCHAREST   (Romania)

ⁱ OTTO VON GUERICKE UNIVERSITY   (Germany)

^j UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^k UNIVERSITY OF VALENCIA   (Spain)

^l CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^m INSTITUTE OF BIOPHYSICS   (Czech Republic)

ⁿ MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^o MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

4 hydroxynonenal; F2 isoprostanes; malondialdehyde; Oxidative stress

Indexed keywords

1 METHYL 2 PHENYLINDOLE; 4 HYDROXYNONENAL; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

BLOOD SAMPLING; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; OXIDATION; PREDICTIVE VALIDITY; REVIEW; SPECTROPHOTOMETRY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

ALDEHYDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CLINICAL CHEMISTRY TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; MALONDIALDEHYDE; MASS SPECTROMETRY; PLASMA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RAYS;

EID: 77956577866     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.499907     Document Type: Review

References (47)

1. Moore K, Roberts LJ, 2nd. Measurement of lipid peroxida-tion. Free Radic Res 1998;28:659-671.
2. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-135.
3. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009;47: 469-484.
4. Birukov KG. Oxidized lipids: the two faces of vascular infl am-mation. Curr Atheroscler Rep 2006;8:223-231.
5. Salomon RG. Isolevuglandins, oxidatively truncated phos-pholipids, and atherosclerosis. Ann NY Acad Sci 2005;1043: 327-342.
6. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-623.
7. Spiteller G. Is atherosclerosis a multifactorial disease or is it induced by a sequence of lipid peroxidation reactions? Ann NY Acad Sci 2005;1043:355-366.
8. Stocker R, Keaney JF, Jr. Role of oxidative modifi cations in atherosclerosis. Physiol Rev 2004;84:1381-1478.
9. Basu S. F-2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Sign 2008;10:1405-1434.
10. Milne GL, Musiek ES, Morrow JD. F-2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005;10:S10-S23.
11. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. Faseb Journal 2004;18: 1791-1800.
12. Griffiths HR, Olinski R, Coolen S, Collins A, Astley SB. Biomarkers. Free Radic Res 2002:36:7-8.
13. Roberts LJ, Morrow JD. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-513.
14. Spickett CM, Wiswedel I, Siems W, Zarkovic K, Zarkovic N. Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res 2010; 44:1172-1202.
15. nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698-710.
16. ESCODD (European Standards Committee on Oxidative DNA Damage). Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 2002;23:2129-2133
17. ESCODD (European Standards Committee on Oxidative DNA Damage). E. S. C. o. O. D. Inter-laboratory validation of procedures for measuring 8-oxo-7,8-dihydroguanine/8-oxo-7,8-dihydro-2 '-deoxyguanosine in DNA. Free Radic Res 2002;36:239-245.
18. Riis B. Comparison of results from different laboratories in measuring 8-oxo-2 '-deoxyguanosine in synthetic oligonucle-otides. Free Radic Res 2002;36:649-659.
19. Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB. Measurement of urinary F-2,-isoprostanes as markers of in vivo lipid peroxidation-a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem1999;272:209-215.
20. Haschke M, Zhang YL, Kahle C, Klawitter J, Korecka M, Shaw LM, Christians U. HPcvfrescf-atmospheric pressure chemical ionization MS/MS for quantifi cation of 15-F2t-isoprostane in human urine and plasma. Clin Chem 2007;53:489-497.
21. Mori T, Croft K, Puddey I, Beilin L. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999;268:117-125.
22. Morrow J, Frei B, Longmire A, Gaziano J, Lynch S, Shyr Y, Strauss W, Oates J, Roberts LN. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-1203.
23. Nourooz-Zadeh J. Key issues in F2-isoprostane analysis. Biochem Soc Trans 2008;36:1060-1065.
24. Wiswedel I, Hirsch D, Kropf S, Gruening M, Pfi ster E, Schewe T, Sies H. Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans. Free Radic Biol Med 2004;37:411-421.
25. Lykkesfeldt J. Determination of malondialdehyde as dithio-barbituric acid adduct in biological samples by HPLC with fl uorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem 2001;47:1725-1727.
26. Grune T, Siems W, Esterbauer H. Comparison of different assays for malondialdehyde using thiobarbituric acid. Fresen J Anal Chem 1992;343:135-135
27. Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer T, Peng Z, Schaur RJ. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 2000;52:181-184.
28. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in pPlasma as measured by lLiquid-chromatographic separation of malondialdehyde thiobarbituric acid adduct. Clin Chem 1987;33:214-220.
29. Londero D, Lo Greco P. Automated high-performance liquid chromatographic separation with spectrofl uorometric detection of a malondialdehyde- thiobarbituric acid adduct in plasma. J Chromatogr A 1996;729:207-210.
30. Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholeste-rolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:76-82.
31. Punchard, N, Kelly F. Free radicals: a practical approach. IRL press at Oxford University Press, Oxford 1996.
32. Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998;11:1176-1183.
33. Borovic S, Rabuzin F, Waeg G, Zarkovic N. ESCODD (European Standards Committee on Oxidative DNA Damage). Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic Res 200640:809-820.
34. Lang J, Celotto C, Esterbauer H. Quantitative-determination of the lipid-peroxidation product 4-hydroxynonenal by high-performance liquid-chromatography. Anal Biochem 1985; 150:369-378.
35. Yoshino K, Matsuura T, Sano M, Saito S, Tomita I. Fluoro-metric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem Pharm Bull (Tokyo) 1986;34:1694-1700.
36. Coolen SA, van Buuren B, Duchateau G, Upritchard J, Verhagen H. Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 2005; 29:429-436.
37. Applegate LA, Scaletta C, Labidi F, Vile GF, Frenk E. Susceptibility of human melanoma cells to oxidative stress including UVA radiation. Int J Cancer 1996;67:430-434.
38. Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spaso-jevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z, Zunic G. Correlation of oxidative stress parameters and infl ammatory markers in coronary artery disease patients. Clin Biochem 2007;40:181-187.
39. Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 2008;45:377-384.
40. Georgiadou P, Iliodromitis E, Varounis C, Mavroidis M, Kolokathis F, Andreadou I, Psarras S, Capetanaki Y, Boudoulas H, Kremastinos DT. Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease. Expert Opin Ther Targ 2008;12:917-920.
41. Kaya C, Erkan AF, Cengiz SD, Dunder I, Demirel OE, Bilgihan A. Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertil Steril 2009;92:1372-1377.
42. Rattan R, Nayak D. High levels of plasma malondialdehyde, protein carbonyl, and fi brinogen have prognostic potential to predict poor outcomes in patients with diabetic foot wounds: a preliminary communication. Int J Low Extrem Wounds 2008;7:198-203.
43. Balsam A, El Kossi MM, Lord R, El Nahas AM. Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival. Hemodial Int 2009;13:278-285.
44. Handelman G, Walter M, Adhikarla R, Gross J, Dallal G, Levin N, Blumberg J. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 2001;59:1960-1966.
45. Sircar D, Subbaiah P V. Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation. Clin Chem 2007;53: 251-258.
46. Nourooz-Zadeh J, Gopaul N, Barrow S, Mallet A, Anggard E. Analysis of F2-isoprostanes as indicators of non-enzymatic in vivo lipid peroxidation by gas chromatography: development of a solid-phase extraction procedure. J Chromatogr 1995;667:199-208.
47. Borovic S, Cipak A, Meinitzer A, Kejla Z, Perovic D, Waeg G, Zarkovic N. Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep 2007;12:50-54.